Camila Guerrero
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Selective B-cell subset depletion underlies increased infection risk in patients with MM treated with anti-BCMA vs anti-GPRC5D bsAbs.
Journal: Blood
Published: April 14, 2025
Selective depletion of B-cell subsets underlies increased risk of infection in MM patients treated with anti-BCMA vs -GPRC5D bsAbs.
Journal: Blood
Published: April 14, 2025
Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers.
Journal: Blood cancer discovery
Published: March 28, 2025
Genetic evidence against clonotypic B-lymphocytes as reservoir of plasma-cell cancers.
Journal: Blood cancer discovery
Published: March 28, 2025
Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 01, 2024
Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma.
Journal: Blood cancer discovery
Published: October 01, 2024
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19.
Journal: Blood cancer journal
Published: March 26, 2024
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 17, 2023
A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable MRD and Survival Outcomes in Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 22, 2021
Last Updated: 09/26/2026